skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Index

Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensions

Muenster, Uwe ; Pelzetter, Christian ; Backensfeld, Thomas ; Ohm, Andreas ; Kuhlmann, Thomas ; Mueller, Hartwig ; Lustig, Klemens ; Keldenich, Jörg ; Greschat, Susanne ; Göller, Andreas H ; Gnoth, Mark Jean

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, August 2011, Vol.78(3), pp.522-30 [Peer Reviewed Journal]

Full text available

View all versions
Citations Cited by
  • Title:
    Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensions
  • Author: Muenster, Uwe ; Pelzetter, Christian ; Backensfeld, Thomas ; Ohm, Andreas ; Kuhlmann, Thomas ; Mueller, Hartwig ; Lustig, Klemens ; Keldenich, Jörg ; Greschat, Susanne ; Göller, Andreas H ; Gnoth, Mark Jean
  • Description: Low solubility of drug candidates generated in research contributes to their elimination during subsequent development due to insufficient oral bioavailability (BA) of crystalline compound. Therefore, the purpose of the study was to identify critical in vitro solubility and dissolution parameter that would predict critical in vivo dissolution by means of in vitro-in vivo correlation. Thermodynamic solubility and apparent dissolution rate (ADR) were determined using the shake-flask method and mini-flow-through-cell, respectively. Oral BA studies in rats and humans were conducted from drug solution and suspension/tablets. Relative BA was calculated using F(rel) [%]=AUC(suspension)/AUC(solution)*100, representing a measure of in vivo dissolution. Roughly, F(rel) rat >50% translates into F(rel) human of >90%. Both, ADR and log volume to dissolve applied dose (VDAD), when plotted against F(rel) rat, revealed certain threshold levels, (ADR, ∼150-200 μg of compound dissolved under respective assay conditions; VDAD, ∼100-500 ml/kg) which translate into F(rel) in rats of >50%. Thus, assuming that F(rel)>50% in rats is indicative of sufficient in vivo dissolution in humans after oral application, drugs should exhibit a VDAD of ∼100-500 ml/kg or less in aqueous media to avoid insufficient or varying drug absorption.
  • Is Part Of: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, August 2011, Vol.78(3), pp.522-30
  • Identifier: E-ISSN: 1873-3441 ; PMID: 21315152 Version:1 ; DOI: 10.1016/j.ejpb.2011.01.023
  • Subjects: Biological Availability ; Pharmaceutical Preparations -- Metabolism
  • Language: English

Searching Remote Databases, Please Wait